Are postnatal hemangioblasts generated by dedifferentiation from committed hematopoietic stem cells?

Experimental Hematology

Volumn 35, Issue 5, 2007, Pages 691-701

  Prindull, Gregor A ^a   Fibach, Eitan ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR E2F1;

BONE MARROW; CARCINOGENESIS; CELL CYCLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELL PROLIFERATION; CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOME 11; CHROMOSOME 14; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; DOWN SYNDROME; EMERY DREIFUSS MUSCULAR DYSTROPHY; EPIGENETICS; FANCONI ANEMIA; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; INTERPHASE; LITERATURE; MITOSIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROGERIA; REVIEW; RNA INTERFERENCE; THYMOCYTE;

ANIMALS; CELL DIFFERENTIATION; CHROMATIN; EPIGENESIS, GENETIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 34247126552     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.01.047     Document Type: Review

References (247)

1. Quesenberry P.J., Dooner G., Colvin G., and Abedi M. Stem cell biology and the plasticity polemic. Exp Hematol 33 (2005) 389-394
2. McConnell S., and Kaznowski C.E. Cell cycle dependence of laminar determination in developing neocortex. Science 254 (1991) 282-285
3. Quesenberry P.J., Colvin G.A., Abedi M., et al. The marrow stem cell: the continuum. Bone Marrow Transplant 32 (2003) S19-S22
4. Prindull G. Hypothesis: Cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells?. Exp Hematol 33 (2005) 738-746
5. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
6. Sell S. Adult stem cell plasticity. Stem Cell Rev 1 (2005) 1-7
7. Orkin S.H., and Morrison S.J. Stem-cell competition. Nature 418 (2002) 25-27
8. Quesenberry P.J., Colvin G.A., and Lambert J.F. The chiaroscuro stem cell: a unified stem cell theory. Blood 100 (2002) 4266-4271
9. Almeida-Porada G., and Zanjani E.D. A large animal noninjury model for study of human stem cell plasticity. Blood Cells Mol Dis 32 (2004) 77-81
10. Almeida-Porada G., Porada C., and Zanjani E.D. Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation. Int J Hematol 79 (2004) 1-6
11. Prindull G. Maturation of cellular and humoral immunity during human embryonic development. Acta Paed Scand 63 (1974) 607-615
12. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., and Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30 (2002) 896-904
13. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
14. Becker P.S., Nilsson S.K., Li Z., et al. Adhesion receptor expression by hematopopietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp Hematol 27 (1999) 533-541
15. Lambert J.F., Liu M., Colvin G.A., et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med 197 (2003) 1563-1572
16. Prindull G., and Zipori D. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 103 (2004) 2892-2899
17. Prindull G. Spontaneous DNA synthesis of blood lymphoid cells in premature newborn infants, in older premature infants, and in full-term newborn infants. Z Kinderheilk 118 (1974) 197-206
18. Prindull G., Prindull B., Ron A., and Yoffey J.M. Cells in spontaneous DNA synthesis in cord blood of premature and full-term newborn infants. An autoradiographic study. J Pediatr 86 (1975) 773-778
19. Prindull G., Prindull B., Schröter W., and Yoffey J.M. Comparison of RNA and DNA synthesis, spontaneous and PHA induced, between blood lymphoid cells of newborn infants, older infants, and adults. A study by scintillation counting and by autoradiography. Eur J Pediatr 126 (1977) 243-252
20. Prindull G., and Hespe A. Fetal blood borne myelo- and thrombopoietic stem cells in diffusion chambers. Eur J Pediatr 129 (1978) 197-204
21. Prindull G, Prindull B, Meulen v.d. N. Haermatopoietic stem cells (CFUc) in human cord blood. Acta Paediatr Scand. 1978;67:413-416.
22. Prindull G., Albani M., Prindull B., and Schröter W. Circulating hematopoietic stem cells in healthy and diseased pre-term infants. Scand J Haematol 25 (1980) 268-274
23. Prindull G., Gabriel M., and Prindull B. Circulating myelopoietic stem cells (CFUc). High levels in healthy pre-term infants and reduced levels in sick pre-term infants. A study by methylcellulose cultures with the addition of exogenous colony stimulating factor (CSF). Blut 43 (1981) 109-111
24. Prindull G., Ben-Ishay Z., Gabriel M., Prindull B., and Schröter W. A comparison of spontaneous and CSA added CFU-GM colony formation in healthy, sick, and hypotrophic pre-term infants. Blut 45 (1982) 167-170
25. Prindull G., Prindull B., Kiekenap R., and Markus B. Radiosensitivity of hematopoietic stem cells (DCPC and CFU-GM) from cord blood. Scand J Haematol 31 (1983) 229-234
26. Prindull G. Early embryonal/fetal lymphopoietic ontogeny and leukemogenesis. Ann Hematol 63 (1991) 291-296
27. Peled T., Glukhman E., Hasson N., et al. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp Hematol 33 (2005) 1092-1100
28. + cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 32 (2004) 547-555
29. + cells. Br J Haematol 116 (2002) 655-661
30. Peled T., Mandel J., Goudsmid R.N., et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 6 (2004) 344-355
31. Prus E., Chandraratna R.A., and Fibach E. Retinoic acid receptor antagonist inhibits CD38 antigen expression on human hematopoietic cells in vitro. Leuk Lymphoma 45 (2004) 1025-1035
32. Prus E., Peled T., and Fibach E. The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells. Leuk Lymphoma 45 (2004) 583-589
33. Jankovic V., Ciarrocchi A., Boccuni P., Benezra R., and Nimer S.U. Id1 regulates the choice of hematopoietic stem cells to self-renew or commit to differentiation. Blood 106 (2005) 82a-83a (abstract #270)
34. Niwa H., Burdon T., Chambers I., and Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12 (1998) 2048-2060
35. Burdon T., Chambers I., Stracey C., Niwa H., and Smith A. Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 165 (1999) 131-143
36. Burdon T., Smith A., and Savatier P. Signalling. Cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 12 (2002) 432-438
37. + population. Exp Hematol 30 (2002) 1070-1078
38. Zipori D. Mesenchymal stem cells: Harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis 33 (2004) 211-215
39. Zambidis E.T., Peault B., Park T.S., Bunz F., and Civin C.I. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106 (2005) 860-870
40. Huber T.L., Kouskoff V., Fehling H.J., Palis J., and Keller G. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432 (2004) 625-630
41. Park C., Ma Y.D., and Choi K. Evidence for the hemangioblast. Exp Hematol 33 (2005) 965-970
42. Willey S., Ayuso-Sacido A., Zhang H., et al. Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factor. Blood 107 (2006) 3122-3130
43. Ferkowicz M.J., and Yoder M.C. Blood island formation: Longstanding observations and modern interpretations. Exp Hematol 33 (2005) 1041-1047
44. Drake C.J., and Fleming P.A. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95 (2000) 1671-1679
45. Kabrun N., Bühring H.J., Choi K., Ullrich A., Risau W., and Keller G. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124 (1997) 2039-2048
46. -/- embryonic stem cells and embryos. Proc Natl Acad Sci U S A 96 (1999) 2159-2164
47. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
48. Joukov V., Kaipainen A., Jeltsch M., et al. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol 173 (1997) 211-215
49. 165 augments erythropoietic development from human embryonic stem cells. Blood 103 (2004) 2504-2512
50. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
51. Fiedler W., Graeven U., Ergün S., et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89 (1997) 1870-1875
52. Göthert J.R., Gustin S.E., van Eekelen J.A.M., Schmidt U., Hall M.A., and Jane S.M. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104 (2004) 1769-1777
53. + cells derived from mouse embryonal stem cells reconstitute hematopoiesis in vivo in SCID mice. Exp Hematol 30 (2002) 1444-1453
54. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., and Keller G. A common precursor for hematopoietic and endothelial cells. Development 125 (1998) 725-732
55. Kennedy M., Firpo M., Choi K., et al. A common precursor for primitive erythropoiesis and definite haematopoiesis. Nature 386 (1997) 488-493
56. Palis J., and Yoder M.C. Yolk-sac hematopoiesis: The first blood cells of mouse and man. Exp Hematol 29 (2001) 927-936
57. Tavian M., Hallais M.F., and Péault B. Emergence of intraembryonic hematopoietic precursors in the pre-liver human embryo. Development 126 (1999) 793-803
58. Godin I., and Cumano A. The hare and the tortoise: An embryonic haematopoietic race. Nat Rev Immunol 2 (2002) 593-604
59. + cells at a diverging point of endothelial and hematopoietic lineages. Development 125 (1998) 1747-1757
60. Cortés F., Debacker C., Péault B., and Labastie M.C. Differential expression of KDR/VEGFR-2 and CD34 during mesoderm development of the early human embryo. Mech Dev 83 (1999) 161-164
61. Damert A., Miquerol L., Gertsenstein M., Risau W., and Nagy A. Insufficient VEGF activity in yolk sac endoderm compromises hematopoietic and endothelial differentiation. Development 129 (2002) 1881-1892
62. Zippo A., DeRobertis A., Bardelli M., Galvagni F., and Oliviero S. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103 (2004) 4536-4544
63. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89 (1997) 981-990
64. Keamey J.B., Ambler C.A., Monaco K.A., Johnson N., Rapoport R.G., and Bautch V.L. Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 99 (2002) 2397-2407
65. Prindull G. Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis. Stem Cell Rev 1 (2005) 277-284
66. Wang L., Menendez P., Cerdan C., and Bhatia M. Hematopoietic development from human embryonic stem cell lines. Exp Hematol 33 (2005) 987-996
67. Yanagisawa K.O., Fujimoto H., and Urushihara H. Effects of the Brachyury (T) mutation on morphogenic movement in the mouse embryo. Dev Biol 87 (1981) 242-248
68. Wilson V., Manson L., Skarnes W.C., and Beddington R.S.P. The T gene is necessary for normal mesodermal morphogenetic cell movements during gastrulation. Development 121 (1995) 877-886
69. Cogle C.R., and Scott E.W. The hemangioblast: cradle to clinic. Exp Hematol 32 (2004) 885-890
70. Ema M., Faloon P., Zhang W.J., et al. Combinational effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 17 (2003) 380-393
71. Robertson S.M., Kennedy M., Shannon J.M., and Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 127 (2000) 2447-2459
72. Shivdasani R.A., Mayer E.L., and Orkin S.H. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 373 (1995) 432-434
73. Zhang W.J., Park C., Arentson E., and Choi K. Modulation of hematopoietic and endothelial cell differentiation from mouse embryonic stem cells by different culture conditions. Blood 205 (2005) 111-114
74. Ernst P., Fisher J.K., Avery W., Wade S., Foy D., and Korsmeyer S.J. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 6 (2004) 437-443
75. Hadland B.K., Huppert S.S., Kanungo J., et al. A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development. Blood 104 (2004) 3097-3105
76. jk dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 132 (2005) 1117-1126
77. McGrath K.E., and Palis J.P. Hematopoiesis in the yolk sac: More than meets the eye. Exp Hematol 33 (2005) 1021-1028
78. Robb L., Lyons I., Li R., et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A 92 (1995) 7075-7079
79. Visvader J.E., Fujiwara Y., and Orkin S.H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 12 (1998) 473-479
80. Jaffredo T., Nottingham W., Liddiard K., Bollerot K., Pouget C., and de Bruijn M. From hemangioblast to hematopoietic stem cell: an endothelial connection?. Exp Hematol 33 (2005) 1029-1040
81. Hirai H., Samokhvalov I.M., Fujimoto T., Nishikawa S., Imanishi J., and Nishikawa S.I. Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells. Blood 106 (2005) 1948-1955
82. North T.E., de Bruijn M.F.T.R., Stacy T., et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16 (2002) 661-672
83. Lacaud G., Gore L., Kennedy M., et al. Runx1 is essential for hematopoietic commitment at the haemangioblast stage of development in vitro. Blood 100 (2002) 458-466
84. Cavalli G. Chromatin as a eukaryotic template of genetic information. Curr Opin Cell Biol 14 (2002) 269-278
85. Wolffe A.P., and Guschin D. Review: Chromatin structural features and targets that regulate transcription. J Struct Biol 129 (2000) 102-122
86. Guasconi V., Souidi M., and Ait-Si-Ali S. Nuclear positioning, gene activity and cancer. Cancer Biol Ther 4 (2005) 134-138
87. Emery A.E.H., and Dreifuss F.E. Unusual type of benign X-linked muscular dystrophy. J Neurol Neurosurg Pyschiatr 29 (1966) 338-342
88. Simon J.A., and Tamkun J.W. Programming off and on states in chromatin: Mechanisms of Polycomb and thrithorax group complexes. Curr Opin Genet Dev 12 (2002) 210-218
89. Croft J.A., Bridger J.M., Boyle S., Perry P., Teague P., and Bickmore W.A. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 145 (1999) 1119-1131
90. Sjakste N.I., and Sjakste T.G. Transcription factors and the nuclear matrix. Mol Biol 35 (2001) 627-635
91. Scheuermann M.O., Murmann A.E., Richter K., Görisch S.M., Herrmann H., and Lichter P. Characterization of nuclear compartments identified by ectopic markers in mammalian cells with distinctly different karyotype. Chromosoma 114 (2005) 39-53
92. Umanskaya O.N., Bystritskiy A.A., and Razin S.V. Chromosome rearrangement breakpoint clustering: The role of clonal selection. Mol Biol 39 (2005) 313-320
93. Stein G.S., van Wijnen A.J., Stein J., Lian J.B., and Montecino M. Contributions of nuclear architecture to transcriptional control. Int Rev Cytol 162A (1995) 251-278
94. Taniura H., Glass C., and Gerace L. A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 131 (1995) 33-44
95. Oehr P. Proteomics as a tool for detection of nuclear matrix proteins and new biomarkers for screening of early tumor stages. Anticancer Res 23 (2003) 805-812
96. Goldman R.D., Gruenbaum Y., Moir R.D., Shumaker D.K., and Spann T.P. Nucelar lamins: Building blocks of nuclear architecture. Genes Dev 16 (2002) 533-547
97. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
98. Görisch S.M., Wachsmuth M., Tóth K.F., Lichter P., and Rippe K. Histone acetylation increases chromatin accessibility. J Cell Sci 118 (2005) 5825-5834
99. Boutanaev A.M., Mikhaylova L.M., and Nurminsky D.I. The pattern of chromosome folding in interphase is outlined by the linear gene density profile. Mol Cell Biol 25 (2005) 8379-8386
100. Chubb J.R., Boyle S., Perry P., and Bickmore W.A. Chromatin motion is constrained by association with nuclear compartments in human cells. Curr Biol 12 (2002) 439-445
101. Görisch S.M., Lichter P., and Rippe K. Mobility of multi-subunit complexes in the nucleus: Accessibility and dynamics of chromatin subcompartments. Histochem Cell Biol 123 (2005) 217-228
102. Francastel C., Schübeler D., Martin D.I.K., and Groudine M. Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol 1 (2000) 137-143
103. Dietzel S., Zolghadr K., Hepperger C., and Belmont A.S. Differential large-scale chromatin compaction and intranuclear positioning of transcribed versus non-transcribed transgene arrays containing β-globin regulatory sequences. J Cell Sci 117 (2004) 4603-4614
104. Cremer T., Kurz A., Zirbel R., et al. Role of chromosome territories in the functional compartmentalization of the cell nucleus. Cold Spring Harb Symp Quant Biol 58 (1993) 777-792
105. Tanabe H., Müller S., Neusser M., et al. Evolutionary conservation of chromosome territory arrangements in cell nuclei from higher primates. Proc Natl Acad Sci U S A 99 (2002) 4424-4429
106. Scheuermann M.O., Tajbakhsh J., Kurz A., Saracoglu K., Eils R., and Lichter P. Topology of genes and nontranscribed sequences in human interphase nuclei. Exp Cell Res 301 (2004) 266-279
107. Eissenberg J.C. Decisive factrors: A transcription activator can overcome heterochromatin silencing. BioEssays 23 (2001) 767-771
108. Yoffey J.M., and Courtice F.C. Lymphatics, lymph and the lymphomyeloid complex (1970), Academic Press, London, New York
109. Yoffey J.M. Stem cell kinetics: correlation of in vivo and in vitro data. Exp Hematol 15 (1987) 110-114
110. Prindull G. Stem cells in the circulation. In: Cohen P. (Ed). Proc XI Int Congr Anat: Advances in the morphology of cells and tissues (1981), Alan R. Liss Inc, New York 243-247
111. Akashi K., He X., Chen J., et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101 (2003) 383-390
112. Shen X., Xiao H., Ranallo R., Wu W.H., and Wu C. Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science 299 (2003) 112-114
113. Steger D.J., Haswell E.S., Miller A.L., Wente S.R., and O'Shea E.K. Regulation of chromatin remodeling by inositol phosphates. Science 299 (2003) 114-116
114. Cosma M.P., Tanaka T., and Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally-regulated promotor. Cell 97 (1999) 299-311
115. Sudarsanam P., and Winston F. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet 16 (2000) 345-351
116. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
117. Zhang Y., and Reinsberg D. Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev 15 (2001) 2343-2360
118. Abu-Daya A., Steer W.M., Trollope A.F., et al. Zygotic nucleosome assembly protein-like 1 has a specific, non-cell autonomous role in hematopoiesis. Blood 106 (2005) 514-520
119. Hiragami K., and Festenstein R. Heterochromatin protein 1: A pervasive controlling influence. Cell Mol Life Sci 62 (2005) 2711-2726
120. Grewal S.I.S., and Elgin S.C.R. Heterochromatin: New possibilities for the inheritance of structure. Curr Opin Genet Dev 12 (2002) 178-187
121. Turner B.M. Histone acetylation and epigenetic code. Bioessays 22 (2000) 836-845
122. Henikoff S., and Ahmad K. Assembly of variant histones into chromatin. Ann Rev Cell Dev Biol 21 (2005) 133-153
123. LeBreton M., Cormier P., Bellé R., Mulner-Lorillon O., and Morales J. Translational control during mitosis. Biochimie 87 (2005) 805-811
124. Eissenberg J.C., Morris G.D., Reuter G., and Hartnett T. The heterochromatin-associated protein HP-1 is an essential protein in Drosophila with dosage-dependent effects on position-effect variegation. Genetics 131 (1992) 345-352
125. Reik W., Dean W., and Walter J. Epigenetic reprogramming in mammalian development. Science 293 (2001) 1089-1093
126. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 3 (2002) 662-673
127. Lachner M., O'Carroll D., Rea S., Mechtler K., and Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410 (2001) 116-120
128. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 16 (2002) 6-21
129. Tagoh H., Melnik S., Lefevre P., Chong S., Riggs A.D., and Bonifer C. Dynamic reorganization of chromatin structure and selective DNA demethylation prior to stable enhancer complex formation during differentiation of primary hematopoietic cells in vitro. Blood 103 (2004) 2950-2955
130. Yoder J.A., Walsh C.P., and Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13 (1997) 335-340
131. Lee J.H., Hart S.R.L., and Skalnik D.G. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 38 (2004) 32-38
132. Bannister A.J., Zegerman P., Partridge J.F., et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410 (2001) 120-124
133. Jacob S., and Moley K.H. Gametes and embryo epigenetic reprogramming affect developmental outcome: implications for assisted reproductive technologies. Pediatr Res 58 (2005) 437-446
134. Schultz R.M., Davus Jr. W., Stein P., and Svoboda P. Reprogramming of gene expression during preimplantation development. J Exp Zool Mol Dev Evol 285 (1999) 276-282
135. Sjakste N., and Sjakste T. Nuclear matrix proteins and hereditary diseases. Russ J Genet 41 (2005) 221-226
136. WAF-1 reorganizes the nucleus in tumor suppression. Proc Natl Acad Sci U S A 95 (1998) 1131-1135
137. Jones P.A. Overview of cancer epigenetics. Semin Hematol 42 (2005) S3-S8
138. Issa J.P. Age-related epigenetic changes and the immune system. Clin Immunol 109 (2003) 103-108
139. Müller H., Bracken A.P., Vernell R., et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15 (2001) 267-285
140. Bachman K.E., Rountree M.R., and Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 276 (2001) 32282-32287
141. Jackson J.P., Lindroth A.M., Cao X., and Jacobsen S.E. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416 (2002) 556-560
142. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3 (2002) 11-20
143. Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., and Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promotors. Nat Genet 25 (2000) 338-342
144. Fuks F., Burgers W.A., Godin N., Kasai M., and Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 20 (2001) 2536-2544
145. MacCorkle R.A., and Tan T.H. Mitogen-activated protein kinases in cell-cycle control. Cell Biochem Biophys 43 (2005) 451-461
146. Bartek J., and Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490 (2001) 117-122
147. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
148. 1 checkpoints-The relationship between the restriction point and phosphorylation of pRB. Exp Cell Res 305 (2005) 383-391
149. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 12 (1998) 2245-2262
150. Bartkova J., Lukas J., and Bartek J. Aberrations of the G1- and G1/S-regulating genes in human cancer. Prog Cell Cycle Res 3 (1997) 211-220
151. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
152. Narita M., Nunez S., Heard E., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
153. Wikenheiser-Brokamp K.A. Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci 63 (2006) 767-780
154. Klar A.J.S. Propagating epigenetic states through meiosis: where Mendel's gene is more than a DNA moiety. Trends Genet 14 (1998) 299-301
155. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
156. Erhardt S., Lyko F., Ainscough J.F.X., Surani M.A., and Paro R. Polycomb-group proteins are involved in silencing processes caused by a transgenic element from the murine imprinted H19/Igf2 region in Drosophila. Dev Genes Evol 213 (2003) 336-344
157. Li T., Vu T.H., Ulaner G.A., et al. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Mol Hum Reprod 11 (2005) 631-640
158. Matzke M.A., and Birchler J.A. RNAi-mediated pathways in the nucleus. Nat Rev Genet 6 (2005) 24-35
159. Tost J., Jammes H., Dupont J.M., et al. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region. Nucleic Acids Res 34 (2006) 5438-5448
160. Szabó P.E., Han L., Hyo-Jung J., and Mann J.R. Mutagenesis in mice of the nuclear hormone receptor binding sites in the Ifg2/H19 imprinting control region. Cytogenet Genome Res 113 (2006) 238-246
161. Hagége H., Nasser R., Weber M., et al. The 3′ portion of the mouse H19 Imprinting Control Region is required for proper tissue-specific expression of the Igf2 gene. Cytogenet Genome Res 113 (2006) 230-237
162. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 suppl (2003) 245-254
163. Engel N., Thorvaldsen J.L., and Bartolomei M.S. CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus. Hum Mol Genet 15 (2006) 2945-2954
164. Kurukuti S., Tiwari V.K., Tavoosidana G., et al. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Proc Natl Acad Sci U S A 103 (2006) 10684-10689
165. Rosa A.L., Wu Y.Q., Kwabi-Addo B., Coveler K.J., Sutton V.R., and Shaffer G.L. Allele-specific methylation of functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32. Chromosome Res 13 (2005) 809-818
166. Thompson J.R., and Williams C.J. Genomic imprinting and assisted reproductive technology: Connections and potential risks. Sem Reprod Med 23 (2005) 285-295
167. Pool T.B. An update on embryo culture for human assisted reproductive technology: Media, performance, and safety. Semin Reprod Med 23 (2005) 309-318
168. Galm O., Wilop S., Lüders C., et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol 84 (2005) 39-46
169. McHeyzer-Williams L.J., Malherbe L.P., and McHeyzer-Williams M.G. Helper T cell-regulated B cell immunity. Curr Top Microbiol Immunol 311 (2006) 59-83
170. Tan J.T., and Surh C.D. T cell memory. Curr Top Microbiol Immunol 311 (2006) 85-115
171. Tarlinton D. B-cell memory: Are subsets necessary?. Nat Rev Immunol 6 (2006) 785-790
172. Bruniquel R.H., and Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4 (2003) 235-240
173. Lund A.H., and van Lohuizen M. Polycomb complexes and silencing mechanisms. Curr Opin Cell Biol 16 (2004) 239-246
174. Wolffe A.P., and Matzke M.A. Epigenetics: Regulation through repression. Science 286 (1999) 481-486
175. Voncken J.W., Schweizer D., Aagaard L., Sattler L., Jantsch M.F., and van Lohuizen M. Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci 112 (1999) 4627-4639
176. Issa J.P. Epigenetic variation and human disease. J Nutr 132 (2002) 2388S-2392S
177. Paro R. Propagating memory of transcriptional states. Trends Genet 11 (1995) 295-297
178. Jackson M., Krassowska A., Gilbert N., et al. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol 24 (2004) 8862-8871
179. Tang X., Milyavsky M., Shats I., Erez N., Goldfinger N., and Rotter V. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 23 (2004) 5759-5769
180. Viré E., Brenner C., Deplus R., et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439 (2006) 871-874
181. 3 lysine methylation and HP1γ are associated with transcription elongation through mammalian chromatin. Blood 106 11, part1 (2005) 493 Abstract #1734
182. Byrne J.A., Simonsson S., Western P.S., and Gurdon J.B. Nuclei of adult mammalian somatic cells are directly reprogrammed to oct-4 stem cell gene expression by amphibian oocytes. Curr Biol 13 (2003) 1206-1213
183. Taranger C.K., Noer A., Sorensen A.L., Hakelien A.M., Boquest A.C., and Collas P. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 16 (2005) 5719-5735
184. Boyer L.A., Lee T.I., Cole M.F., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122 (2005) 947-956
185. Landsverk H.B., Hakelien A.M., Küntziger T., Robl J.M., Skalhegg B.S., and Collas P. Reprogrammed gene expression in a somatic cell-free extract. EMBO Rep 3 (2002) 384-389
186. Hakelien A.M., Landsverk H.B., Robl J.M., Skalhegg B.S., and Collas P. Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat Biotechnol 20 (2002) 460-466
187. Hakelien A.M., Gaustad K.G., Taranger C.K., Skalhegg B.S., Küntziger T., and Collas P. Long-term in vitro, cell-type-specific genome-wide reprogramming of gene expression. Exp Cell Res 309 (2005) 32-47
188. O'Malley K., and Scott E.W. Stem cell fusion confusion. Exp Hematol 32 (2004) 131-134
189. Cowan C.A., Atienza J., Melton D.A., and Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (2005) 1369-1373
190. Terada N., Hamazaki T., Oka M., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
191. Pells S., Di Domenico A.I., Gallagher E.J., and McWhir J. Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro. Cloning Stem Cells 4 (2002) 331-338
192. Ying Q.L., Nichols J., Evans E.P., and Smith A.G. Changing potency by spontaneous fusion. Nature 416 (2002) 545-548
193. Weimann J.M., Johansson C.B., Trejo A., and Blau H.M. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 5 (2003) 959-966
194. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
195. Giguere L., and Morais R. On suppression of tumorigenesis in hybrid and cybrid mouse cells. Somatic Cell Genet 7 (1981) 457-471
196. Anderson M.J., and Stanbridg E.J. Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J 7 (1993) 826-833
197. Cibelli J.B., Stice S.L., Golueke P.J., et al. Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat Biotechnol 16 (1998) 642-646
198. Wakayama T., Tabar V., Rodriguez I., Perry A.C.F., Studer L., and Mombaerts P. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292 (2001) 740-743
199. Munsie M.J., Michalska A.E., O'Brien C.M., Trounson A.O., Pera M.F., and Mountford P.S. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol 10 (2000) 989-992
200. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., and Campbell K.H.S. Viable offspring derived from fetal and adult mammalian cells. Nature 385 (1997) 810-813
201. Wilmut I., Beaujean N., de Sousa P.A., et al. Somatic cell nuclear transfer. Nature 419 (2002) 583-586
202. Gurdon J.B., and Byrne J.A. The first half-century of nuclear transplantation. Proc Natl Acad Sci U S A 100 (2003) 8048-8052
203. Santos F., Zakhartchenko V., Stojkovic M., et al. Epigenetic marking correlates with developmental potential in cloned bovine preimplantation embryos. Curr Biol 13 (2003) 1116-1121
204. Humpherys D., Eggan K., Akutsu H., et al. Epigenetic instability in ES cells and cloned mice. Science 293 (2001) 95-97
205. Gao S., and Latham K.E. Maternal and environmental factors in early cloned embryo development. Cytogenet Genome Res 105 (2004) 279-284
206. Tamada H., and Kikyo N. Nuclear reprogramming in mammalian somatic cell nuclear cloning. Cytogenet Genome Res 105 (2004) 285-291
207. Campbell K.H.S., Loi P., Otaegui P.J., and Wilmut I. Cell cycle co-ordination in embryo cloning by nuclear transfer. Rev Reprod 1 (1996) 40-46
208. Bloor D.J., Metcalfe A.D., Rutherford A., Brison D.R., and Kimber S.J. Expression of cell adhesion molecules during human preimplantation embryo development. Mol Hum Reprod 8 (2002) 237-245
209. Kidder G.M., and Winterhager E. Intercellular communication in preimplantation development: the role of gap junctions. Front Biosci 6 (2001) D731-D736
210. Houghton F.D., Barr K.J., Walter G., et al. Functional significance of gap junctional coupling in preimplantation development. Biol Reprod 66 (2002) 1403-1412
211. Perez-Pomares J.M., and Munoz-Chapuli E. Epithelial-mesenchymal transitions: A mesodermal cell strategy for evolutive innovation in metazoans. Anat Rec 268 (2002) 343-351
212. Yokoyama K., Kamata N., Fujimoto R., et al. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinoma. Int J Oncol 22 (2003) 891-898
213. Gotzmann J., Mikula M., Eger A., et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566 (2004) 9-20
214. Brabletz T., Hlubek F., Spaderna S., et al. Invasion and metastasis in colorectal cancer: Epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin. Cells Tissues Organs 179 (2005) 56-65
215. Kirchner T., Müller S., Hattori T., et al. Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virch Arch 439 (2001) 512-522
216. Ougolkov A.V., Fernandez-Zapico M.E., Bilim V.N., Smyrk T.C., Chari S.T., and Billadeau D.D. Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer: Association with kinase activity and tumor dedifferentiation. Clin Cancer Res 12 (2006) 5074-5081
217. Draisma G., Postma R., Schröder F.H., van der Kwast T.H., and de Koning H.J. Gleason score, age and screening: Modeling dedifferentiation in prostate cancer. Int J Cancer 119 (2006) 2366-2371
218. Peinado H., Portillo F., and Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48 (2004) 365-375
219. Hay E.D. An overview of epithelio-mesenchymal transformation. Acta Anat 154 (1995) 8-20
220. Vandewalle C., Comijn J., De Craene B., et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acid Res 33 (2005) 6566-6578
221. Tester A.M., Ruangpanit N., Anderson R.L., and Thompson E.W. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits. Clin Exp Metastasis 18 (2001) 553-560
222. Cai J., Weiss M.L., and Rao M.S. In search of "stemness.". Exp Hematol 32 (2004) 585-598
223. Joshi C.V., and Enver T. Plasticity revisited. Curr Opin Cell Biol 14 (2002) 749-755
224. Walder S., Zhang F., and Ferretti P. Upregulation of stem cell markers suggests the occurrence of dedifferentiation in regenerating spinal cord. Dev Genes Evol 213 (2003) 625-630
225. McGann C.J., Odelberg S.J., and Keating M.T. Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci U S A 98 (2001) 13699-13704
226. Velloso C.P., Simon A., and Brockes J.P. Mammalian postmitotic nuclei reenter the cell cycle after serum stimulation in newt/mouse hybrid myotubes. Curr Biol 11 (2001) 855-858
227. Jögi A., Ora I., Nilsson H., et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A 99 (2002) 7021-7026
228. Helczynska K., Kronblad A., Jögi A., et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 63 (2003) 1441-1444
229. Lal A., Peters H., Croix B.S., et al. Transcriptional response to hypoxia in human tumors. J Nat Cancer Inst 93 (2001) 1337-1343
230. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
231. Kondo T., and Raff M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289 (2000) 1754-1757
232. Kang S.K., Park J.B., and Cha S.H. Multipotent, dedifferentiated cancer stem-like cells from brain gliomas. Stem Cells Dev 15 (2006) 423-435
233. Wagers A.J., Sherwood R.I., Christensen J.L., and Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297 (2002) 2256-2259
234. Castro R.E., Jackson K.A., Goodell M.A., Robertson C.S., Liu H., and Shine H.D. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 297 (2002) 1299-1302
235. Bailey A.S., Jiang S., Afentoulis M., et al. Transplanted adult hematopoietic stem cells differentiate into functional endothelial cells. Blood 103 (2004) 13-19
236. Grant M.B., May W.S., Caballero S., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8 (2002) 607-612
237. Fang B., Zheng C., Liao L., et al. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 105 (2005) 2733-2740
238. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
239. Pelosi E., Valtieri M., Coppola S., et al. Identification of the hemangioblast in postnatal life. Blood 100 (2002) 3203-3208
240. Cogle C.R., Wainman D.A., Jorgensen M.L., Gutherie S.M., Mames R.N., and Scott E.W. Adult human hematopoietic cells provide functional hemangioblast activity. Blood 103 (2004) 133-135
241. Loges S., Fehse B., Brockmann M.A., et al. Identification of the adult human hemangioblast. Stem Cells Dev 13 (2004) 229-242
242. Ziegler B.L., Valtieri M., Almeida-Porada G., et al. KDR receptor: A key marker defining hematopoietic stem cells. Science 285 (1999) 1553-1558
243. Zhao Y., Glesne D., and Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100 (2003) 2426-2431
244. Minasi M.G., Riminucci M., DeAngelis L., et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129 (2002) 2773-2783
245. Bailey A.S., Willenbring H., Jiang S., et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci U S A 103 (2006) 13156-13161
246. Colvin G.A., Lambert J.F., Moore B.E., et al. Intrinsic hematopoietic stem cell/progenitor plasticity: Inversions. J Cell Physiol 199 (2004) 20-31
247. Kögler G., Sensken S., Airey J.A., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200 (2004) 123-135